Geneesmiddelenbeleid
This procedure is a motion concerning the national policy for medicines. It seeks to address how pharmaceutical products are managed, accessed, and regulated to ensure public health and sustainable healthcare spending. This affects the healthcare sector, pharmaceutical companies, and patients by potentially altering how medications are priced, procured, or distributed within the Netherlands.
National vote coverage: Netherlands-only